COVID-19: Recent Advances in Lung Ultrasound

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV 2) has become a global threat that has led to tremendous societal instability. The SARS-CoV- 2 can exhibit a drastic variation in terms of the signs and symptoms in the patient’s body. This virus manifests its existence through cough, fever, sore throat, body aches, chest pain, headaches, and dyspnoea. These can lead to life-threatening respiratory insufficiency, thereby affecting several other organs such as the kidney, heart, lungs, liver, and nervous system. The lungs are the primary target site for SARS-CoV-2 and several diagnoses are being deployed in real time for treatment purposes. Although chest CT is the standard method for early diagnosis and management of Coronavirus Disease (COVID-19), lung ultrasound (US) has some merits over chest CT and may be used in addition to it in the workup of COVID-19. The goal of our review is to look at the observations of the reports on lung ultrasound in COVID-19 patients and the current advances.